Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introduction.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2018
Same author

The Role of Civil Commitment in the Opioid Crisis.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2018
Same author

Improving Rural Access to Opioid Treatment Programs.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2018
Same author

The Opioid Crisis and Federal Criminal Prosecution.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2018
Same author

Fentanyl: A Whole New World?

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2018

Related Experiment Video

Updated: Feb 6, 2026

Extraction of High Molecular Weight DNA from Microbial Mats
09:30

Extraction of High Molecular Weight DNA from Microbial Mats

Published on: July 7, 2011

20.1K

Buprenorphine MAT as an Imperfect Fix.

Brian Mund1, Kate Stith1

  • 1Brian Mund, J.D., received his B.A. from the University of Pennsylvania and his J.D. from Yale Law School. Kate Stith, J.D., is the Lafayette S. Foster Professor of Law at Yale Law School. She received her B.A. from Dartmouth College, and her M.P.P. and J.D. from Harvard University.

The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|August 28, 2018
PubMed
Summary

Expanding buprenorphine access needs careful evaluation of its benefits and risks. Ongoing assessment is crucial to manage potential dangers like misuse and diversion during increased availability.

More Related Videos

Expansion of Two-dimension Electrospun Nanofiber Mats into Three-dimension Scaffolds
06:14

Expansion of Two-dimension Electrospun Nanofiber Mats into Three-dimension Scaffolds

Published on: January 7, 2019

7.3K
Author Spotlight: Real-Time Imaging of Bonding in 3D-Printed Layers
04:36

Author Spotlight: Real-Time Imaging of Bonding in 3D-Printed Layers

Published on: September 1, 2023

3.9K

Related Experiment Videos

Last Updated: Feb 6, 2026

Extraction of High Molecular Weight DNA from Microbial Mats
09:30

Extraction of High Molecular Weight DNA from Microbial Mats

Published on: July 7, 2011

20.1K
Expansion of Two-dimension Electrospun Nanofiber Mats into Three-dimension Scaffolds
06:14

Expansion of Two-dimension Electrospun Nanofiber Mats into Three-dimension Scaffolds

Published on: January 7, 2019

7.3K
Author Spotlight: Real-Time Imaging of Bonding in 3D-Printed Layers
04:36

Author Spotlight: Real-Time Imaging of Bonding in 3D-Printed Layers

Published on: September 1, 2023

3.9K

Area of Science:

  • Pharmacology
  • Public Health
  • Addiction Medicine

Background:

  • Buprenorphine is a key medication for opioid use disorder treatment.
  • Expanding access to buprenorphine is a national priority.
  • Balancing treatment benefits against misuse risks is essential.

Purpose of the Study:

  • To outline the need for evidence-based decision-making regarding buprenorphine access.
  • To highlight the importance of considering both benefits and dangers of buprenorphine.
  • To emphasize continuous evaluation throughout access expansion.

Main Methods:

  • This study is a review and synthesis of existing literature and policy considerations.
  • It involves analyzing data on buprenorphine efficacy and diversion risks.
  • Expert consensus and risk-benefit analysis frameworks are considered.

Main Results:

  • Increased buprenorphine access offers significant therapeutic benefits for opioid use disorder.
  • Potential risks include misuse, diversion, and associated public health concerns.
  • Careful monitoring and risk mitigation strategies are necessary.

Conclusions:

  • Evidence-based strategies are required to maximize buprenorphine's benefits while minimizing its harms.
  • Ongoing evaluation at all stages of access expansion is critical.
  • A balanced approach is necessary for safe and effective buprenorphine utilization.